Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 30 04:00PM ET
24.28
Dollar change
-0.07
Percentage change
-0.30
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y- Shs Outstand Perf Week0.36%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings46 Perf Month-6.58%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM10.70M Perf Quarter-4.28%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range23.67 - 26.74 Perf YTD-4.77%
Dividend TTM- ESG Type Tags- Flows% 3M218.76% 52W High-9.20% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD30864.19% 52W Low2.57% ATR (14)0.24
Expense0.75% Structure Type Region Flows% 1Y RSI (14)43.54 Volatility0.56% 0.47%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.18 Prev Close24.35
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume2.52K Price24.28
SMA20-1.07% SMA50-4.32% SMA200-4.42% Trades Volume451 Change-0.30%
Tema Neuroscience And Mental Health ETF seeks to provide long-term growth of capital. Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.